Drug Resistance, Bacterial
"Drug Resistance, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
| Descriptor ID |
D024881
|
| MeSH Number(s) |
G06.099.225 G06.225.347 G07.690.773.984.269.347
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Bacterial" by people in this website by year, and whether "Drug Resistance, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 1 | 2 | | 2002 | 0 | 2 | 2 | | 2003 | 1 | 3 | 4 | | 2004 | 1 | 2 | 3 | | 2006 | 2 | 2 | 4 | | 2007 | 1 | 2 | 3 | | 2008 | 1 | 1 | 2 | | 2009 | 3 | 2 | 5 | | 2010 | 2 | 3 | 5 | | 2011 | 4 | 7 | 11 | | 2012 | 5 | 3 | 8 | | 2013 | 2 | 2 | 4 | | 2014 | 6 | 2 | 8 | | 2015 | 4 | 4 | 8 | | 2016 | 4 | 3 | 7 | | 2017 | 3 | 6 | 9 | | 2018 | 9 | 7 | 16 | | 2019 | 7 | 4 | 11 | | 2020 | 3 | 8 | 11 | | 2021 | 1 | 8 | 9 | | 2022 | 3 | 1 | 4 | | 2023 | 1 | 4 | 5 | | 2024 | 0 | 1 | 1 | | 2025 | 5 | 2 | 7 | | 2026 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.
-
Detweiler CS, Alav I. How resistance-nodulation-division (RND) efflux pumps contribute to virulence. PLoS Pathog. 2026 05; 22(5):e1014228.
-
Hibberd PL, Kim JH, Trotta M, Leal SM, Aceituno A, Ward DV, Patel A, Subramaniam A, Carlo WA, Ahmed I, Saleem S, Billah SM, Haque R, Mazariegos M, Esamai F, Somannavar MS, Goudar SS, Chomba E, Mwenchanya M, Lokangaka A, Tshefu A, Goldenberg RL, Bauserman M, Krebs NF, Bucher S, Derman RJ, Petri WA, Koso-Thomas M, Babineau DC, McClure EM, Tita ATN. Impact of prophylactic oral azithromycin during labor on Azithromycin Resistance (AMR) in nasal Staphylococcus aureus and Streptococcus pneumoniae in women and infants in the multi-country Azithromycin Prevention in Labor Use Study (A-PLUS). PLoS One. 2026; 21(4):e0346174.
-
Penaranda C, Brenner EP, Clatworthy AE, Cosimi LA, Ravi J, Hung DT. Genomic comparison and phenotypic characterization of Pseudomonas aeruginosa isolates across environmental and diverse clinical isolation sites. mSystems. 2026 Mar 24; 11(3):e0136225.
-
Detweiler CS, Alav I. Beyond antibiotic resistance: evidence for resistance-nodulation-division (RND) efflux pumps as virulence determinants. Microbiol Mol Biol Rev. 2025 Dec 18; 89(4):e0027824.
-
Arya G, Chodisetti PK, Espinosa J, Russo BC, Hang HC, Duerkop BA. Enterococcus faecium sagA mutants have cell envelope defects influencing antibiotic resistance and bacteriophage susceptibility. J Bacteriol. 2025 Nov 20; 207(11):e0030225.
-
Russell JN, Kos D, Yacoub E, Sies AN, Warr B, Jelinski M, Ruzzini A, Cameron ADS. Enhanced metagenomic surveillance for bovine respiratory disease pathogens and antimicrobial resistance by hybridization capture sequencing. Appl Environ Microbiol. 2025 Oct 22; 91(10):e0097725.
-
Ghosh A, Vang CK, Brenner EP, Ravi J. Unlocking antimicrobial resistance with multiomics and machine learning. Trends Microbiol. 2025 Oct; 33(10):1048-1051.
-
Lu D, Kalantar KL, Glascock AL, Chu VT, Guerrero ES, Bernick N, Butcher X, Ewing K, Fahsbender E, Holmes O, Hoops E, Jones AE, Lim R, McCanny S, Reynoso L, Rosario K, Tang J, Valenzuela O, Mourani PM, Pickering AJ, Raphenya AR, Alcock BP, McArthur AG, Langelier CR. Simultaneous detection of pathogens and antimicrobial resistance genes with the open source, cloud-based, CZ ID platform. Genome Med. 2025 May 06; 17(1):46.
-
Tran SL, Lebreuilly L, Cormontagne D, Samson S, Tô TB, Stosskopf M, Dervyn R, Grießhammer A, de la Cuesta-Zuluaga J, Maier L, Naas T, Mura S, Rognan D, Nicolas J, André G, Ramarao N. An anti-virulence drug targeting the evolvability protein Mfd protects against infections with antimicrobial resistant ESKAPE pathogens. Nat Commun. 2025 Apr 28; 16(1):3324.
-
Ray S, Flemming LK, Scudder CJ, Ly MA, Porterfield HS, Smith RD, Clark AE, Johnson JK, Das S. Comparative phenotypic and genotypic antimicrobial susceptibility surveillance in Achromobacter spp. through whole genome sequencing. Microbiol Spectr. 2025 Apr; 13(4):e0252724.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|